SecSonar.com

BioAge Labs, Inc. (BIOA)

BioAge Labs, Inc. at a glance — key fundamentals, SEC filings, insider buying and selling, and earnings dates.

BioAge Labs, Inc. (BIOA) is a Biotechnology company based in US with a market capitalization of $646.1M. Free cash flow was negative at -$82.3M. This page tracks BIOA's SEC filings, insider buying and selling, earnings dates, and key fundamentals in one place.

US · 62 employees · IPO Sep 26, 2024

Valuation

Valuation & price

$17.66 · as of May 17, 2026 · -29.6% vs 52w high

—

P/E ratio

Latest-FY diluted EPS

2.37

P/B ratio

Market cap ÷ book equity

—

Dividend yield

Price — last 12 months

$25.10$14.64$4.18Jul 25Dec 25Jul 26Jul 7, 25$4.18Jul 9, 25$4.63Jul 11, 25$4.56Jul 15, 25$4.52Jul 17, 25$4.80Jul 21, 25$4.60Jul 23, 25$4.85Jul 25, 25$4.62Jul 29, 25$4.48Jul 31, 25$4.40Aug 4, 25$4.42Aug 6, 25$4.33Aug 11, 25$4.34Aug 13, 25$4.56Aug 15, 25$4.55Aug 19, 25$4.42Aug 21, 25$4.50Aug 25, 25$4.51Aug 27, 25$4.74Aug 29, 25$4.93Sep 3, 25$4.74Sep 5, 25$4.76Sep 9, 25$4.98Sep 11, 25$4.91Sep 16, 25$4.90Sep 18, 25$5.22Sep 22, 25$5.11Sep 24, 25$5.31Sep 26, 25$5.42Sep 30, 25$5.88Oct 2, 25$5.90Oct 6, 25$5.63Oct 8, 25$5.67Oct 10, 25$5.35Oct 14, 25$5.51Oct 16, 25$5.11Oct 21, 25$5.30Oct 23, 25$7.95Oct 27, 25$7.63Oct 29, 25$7.68Oct 31, 25$7.57Nov 4, 25$7.47Nov 6, 25$7.47Nov 10, 25$7.49Nov 12, 25$8.01Nov 14, 25$7.80Nov 18, 25$8.25Nov 20, 25$8.59Nov 25, 25$9.00Nov 28, 25$9.49Dec 2, 25$8.49Dec 4, 25$10.50Dec 8, 25$11.83Dec 10, 25$12.68Dec 12, 25$12.88Dec 16, 25$12.51Dec 18, 25$12.38Dec 22, 25$13.58Dec 24, 25$14.08Dec 29, 25$13.84Jan 2, 26$12.83Jan 6, 26$15.41Jan 8, 26$13.92Jan 12, 26$17.85Jan 14, 26$22.92Jan 16, 26$20.16Jan 21, 26$20.12Jan 23, 26$18.81Jan 27, 26$19.60Jan 29, 26$19.10Feb 2, 26$20.10Feb 4, 26$20.15Feb 9, 26$20.51Feb 11, 26$19.99Feb 13, 26$19.57Feb 18, 26$19.59Feb 20, 26$20.51Feb 24, 26$21.56Feb 26, 26$22.32Mar 2, 26$21.71Mar 4, 26$21.07Mar 6, 26$20.29Mar 10, 26$20.97Mar 12, 26$19.89Mar 17, 26$21.22Mar 19, 26$21.04Mar 23, 26$18.63Mar 25, 26$16.41Mar 27, 26$16.15Mar 31, 26$17.49Apr 2, 26$17.50Apr 7, 26$17.61Apr 9, 26$17.79Apr 13, 26$16.19Apr 15, 26$16.97Apr 17, 26$18.49Apr 22, 26$18.36Apr 24, 26$17.05Apr 28, 26$17.44Apr 30, 26$16.85May 4, 26$16.62May 6, 26$18.46May 8, 26$17.99May 12, 26$18.19May 14, 26$18.72May 18, 26$15.34May 20, 26$16.11May 22, 26$16.61May 28, 26$17.05Jun 1, 26$17.20Jun 3, 26$16.04Jun 5, 26$15.70Jun 9, 26$15.80Jun 11, 26$16.45Jun 15, 26$19.84Jun 17, 26$19.99Jun 22, 26$21.47Jun 24, 26$22.83Jun 26, 26$23.76Jul 2, 26$25.10
$4.1252-week range$25.10
Loading valuation history…

Fundamentals

Key fundamentals

$646.1M

Market cap

—

Revenue growth (YoY)

100.0%

Gross margin

-$82.3M

Free cash flow (USD)

-$275.5M

Net debt

Net cash position

0.2%

Share dilution

1/4

Graham criteria passed

Defensive-investor screen

Healthcare

Sector

Trajectory

Long-term trends

Revenue by year

2022 → 2025

FY 2022$0.00FY 2023$0.00FY 2024$0.00FY 2025$9.0M
$0$9M

Free cash flow by year

2022 → 2025

FY 2022$-36.3MFY 2023$-37.5MFY 2024$-51.9MFY 2025$-82.3M
-$36.3M-$82.3M

Value screen

Graham defensive-investor tests

Computing the scorecard — refreshing any stale inputs…

0

Insider buys · 90 days

1

Insider sells · 90 days

Earnings

Last report: 10-Q filed May 8, 2026

Next expected: not yet scheduled

On the tape

Recent SEC & insider activity

  • Insider sellInsider Sell $1.6M · 10b5-1 PlanBarton Shane · Principal Accounting Officer · $1.6MJul 1, 2026Filing
  • 8-K eventAnnual Meeting ResultsJun 12, 2026Filing
  • Quarterly report10-Q FiledMay 8, 2026Filing
  • 8-K eventEarnings ReleaseMay 8, 2026Filing
  • Insider sellInsider Sell $157K · 10b5-1 PlanRUBIN PAUL D · Chief Medical Officer · $157.1KApr 3, 2026Filing

Questions

Frequently asked questions

What is BioAge Labs, Inc.'s market cap?

BioAge Labs, Inc. (BIOA) has a market capitalization of $646.1M.

What is BIOA's P/E ratio?

A meaningful P/E ratio is not available for BIOA — the company's latest fiscal-year earnings per share is zero, negative, or not yet cached.

What is BIOA's price-to-book (P/B) ratio?

BIOA trades at 2.37 times book value per share.

Are insiders buying BIOA stock?

SEC Form 4 filings show no open-market insider buys at BioAge Labs, Inc. in the last 90 days (1 sell).

Same arena

Related companies in Biotechnology

ESPR

Esperion Therapeutics, Inc.

$650.8M

ANL

Adlai Nortye Ltd.

$652.4M

CRMD

CorMedix Inc.

$659.8M

PRME

Prime Medicine, Inc.

$632.2M

DNA

Ginkgo Bioworks Holdings, Inc.

$628.4M

PROK

ProKidney Corp.

$621.5M

Timeline

Every filing, insider trade & earnings on a price-anchored timeline

Filing Analyzer

Search the actual 10-K / 10-Q text with AI research angles

News

Latest press coverage in one feed

Data: SEC EDGAR filings and cached fundamental data; prices and ratios use the most recent cached quote and statements (may lag by up to a day). Educational and research purposes only. Not investment advice.